Sasha Afanassiev

Aphton Corp. operates as a biopharmaceutical company, which is focused on the development and commercialization of pharmaceutical products for the treatment of cancer and gastrointestinal disease. The company was founded on May 12, 1981 and is headquartered in Philadelphia, PA.

Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA.

Founded in 1999 by the late Thomas Watson, Janney Montgomery Scott LLC (JMS) is a full-service financial services firm and registered broker/dealer headquartered in Philadelphia, Pennsylvania. The firm is a subsidiary of Independence Square Properties LLC, itself a subsidiary of Penn Mutual Insurance Co. Their ultimate parent is Harleysville Mutual Insurance Co. JMS is a member of the NYSE, the SIPC and FINRA. The firm provides comprehensive financial advice and services to individual, corporate and institutional investors. Their primary coverage verticals include the consumer, technology, financials and infrastructure sectors.

US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD.

Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski.

Insyght Interactive, Inc. offers scientific and commercial strategic services for the pharmaceutical and biotechnology industries. Its services include leader engagement/management, electronic strategy and digital applications, and strategic consulting. The company was founded by Rina Yasuda in 1996 and is headquartered in Los Angeles, CA.

Footwear Unlimited, Inc. operates as a footwear manufacturer and wholesaler. The company was incorporated in 1966 and is headquartered in Fenton, MO.

Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ.

Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ.

Vella Bioscience, Inc. is a consumer product company that focuses on improving women's sexual wellbeing. The company is based in Worcester, MA. The company operates at the intersection of biotech and wellness and aims to address the specific needs of female bodies. The company's flagship product is the award-winning women's pleasure serum, which is scientifically proven to enhance a woman's arousal and orgasm. Vella Bioscience was founded in 2020 by Michael Frid, Nial C. DeMena, Carolyn Wheeler, and Harin Padma-Nathan, with Carolyn Wheeler serving as the CEO since then.

Linnaeus Therapeutics LLC is a development-stage biotech company that identifies and develops small molecule agents for the treatment of various cancers. The private company is based in Philadelphia, PA. The company's compounds can be used to increase or decrease pigmentation and provide a UV-protecting tan without DNA damage. The company was founded in 2016 by Christopher Natale, Todd Ridky, and the CEO is Patrick T. Mooney. The company also focuses on modulating melanocyte pigmentation to correct genetic and acquired skin pigmentation conditions.